William H. Frishman

Papers

Total Citations

H-Index

About

William H. Frishman is a towering figure in cardiovascular medicine, whose research has profoundly shaped the understanding and treatment of heart disease. His key contributions span clinical cardiology, hypertension, and heart failure, with a particular focus on the pharmacologic management of these conditions. Dr. Frishman is renowned for his pioneering work on calcium channel blockers and beta-blockers, elucidating their mechanisms and clinical applications. He has authored over 500 peer-reviewed papers, with his most cited works accumulating thousands of citations, reflecting his enduring influence on the field. Notably, his research has advanced the use of robotic-assisted percutaneous coronary intervention, as seen in his 2022 meta-analysis, which systematically evaluated its benefits over manual procedures. Dr. Frishman’s impact extends beyond research; he has served as editor-in-chief of major cardiology journals and mentored countless trainees. His dedication to evidence-based medicine and innovation has earned him numerous accolades, including the American Heart Association’s Distinguished Scientist Award. For students and researchers, Frishman’s work exemplifies how rigorous investigation can translate directly into improved patient care.